Skip to main content
Hit enter to search or ESC to close
Close Search
Lauxera Capital PartnersLauxera Capital PartnersLauxera Capital Partners
search
Menu
  • LP Portal
  • search
  • Menu

Fierce Biotech – LUMICKS snags £93M for its molecular tweezers and cell therapy hardware

Par WeAreBlow19 April 2021December 3rd, 2025No Comments

Fierce Biotech – LUMICKS snags £93M for its molecular tweezers and cell therapy hardware

https://www.fiercebiotech.com/medtech/lumicks-snags-93m-for-its-molecular-tweezers-and-cell-therapy-hardware?mkt_tok=Mjk0LU1RRi0wNTYAAAF8igMUtlBIdahGhfVHfuZPT8bUmAzF958avUNCMmYQPPwgnw3eLOiQb00C2v7YWrzTxX8oHSuJt1FeAy4gqwI9f7Ys6DBkgiBJPLEAkfh24wWuKwQ&mrkid=936965

Scaling impact in Healthtech

Home
About us
Team
Portfolio
Stories
ESG
News
Contact

Paris

41 Avenue de Friedland
75008 Paris
France

San Francisco

129 Miller Ave, Ste 824
Mill Valley, CA 94941
USA

© 2025 Lauxera Partners – All rights reserved / Credits

Legal mentions / Personal data

LinkedIn

Close Menu
  • LP Portal
  • About us
  • Team
  • Portfolio
  • Stories
  • ESG
  • News
  • Contact
  • LinkedIn
  • LP Portal
We use cookies to ensure you get the best experience on our website. If you continue to use this site, we will assume that you are happy with it.